Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on November 5, 2026

Nov. 5, 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

Indeterminate GlobeNewswire

Nov. 5, 2026

Tangram kündigt eine mündliche Präsentation der präklinischen Daten zu TGM-148 an, in der der kontextabhängige Wirkmechanismus im Mittelpunkt steht; die Präsentation findet im Rahmen der Jahrestagung 2026 der American Society of Hematology (ASH)…

Indeterminate GlobeNewswire

Nov. 5, 2026

Tangram annonce la présentation orale des données précliniques sur le TGM-148, mettant en évidence son mécanisme d’action dépendant du contexte, à l’occasion du congrès annuel 2026 de l’American Society of Hematology (ASH)

Indeterminate GlobeNewswire

Nov. 5, 2026

Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance

Indeterminate GlobeNewswire

Nov. 5, 2026

AVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027

Indeterminate GlobeNewswire

Nov. 5, 2026

NorthStrive Biosciences Announces Results from EL-32 Preclinical Combination Study with Semaglutide and Plans for Next Phase of Development

Indeterminate GlobeNewswire

Nov. 5, 2026

Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance

Indeterminate GlobeNewswire

Nov. 5, 2026

Cronos Group Reports 2026 Third Quarter Results

Indeterminate GlobeNewswire

Nov. 5, 2026

SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Medicus Pharma to Present at BIO-Europe 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Palvella Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide

Indeterminate GlobeNewswire

Nov. 5, 2026

Newsweek Places KFSH Riyadh in Top 5% of World’s Best Hospitals & Clinics for Medical Tourism 2027

Indeterminate GlobeNewswire

Nov. 5, 2026

Addgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life Sciences

Indeterminate GlobeNewswire

Nov. 5, 2026

Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals

Indeterminate GlobeNewswire

Nov. 5, 2026

Akebia Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design 

Indeterminate GlobeNewswire

Nov. 5, 2026

Nurix Therapeutics to Present New and Updated Data from Ongoing Phase 1a/1b Trial of Bexobrutideg (NX-5948) in Relapsed/Refractory CLL/SLL at the 68th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire